Adaptive trial design in play aka repowering calculation to achieve maximum patient benefit available, reduce costs and define true benefit or otherwise. very positive imo but open to interpretation
plenty to like - thanks @hottod
glah
- Forums
- ASX - By Stock
- AVE
- Who's Buying
AVE
avecho biotechnology limited
Add to My Watchlist
0.00%
!
0.4¢

Who's Buying, page-54
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.69M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $24.40K | 6.101M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 22260255 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 5451823 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 22260255 | 0.003 |
14 | 12450200 | 0.002 |
15 | 57221222 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 5451823 | 2 |
0.005 | 20246648 | 22 |
0.006 | 31623747 | 5 |
0.007 | 4498187 | 12 |
0.008 | 4597500 | 5 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online